Cargando…
A Recombinant Oncolytic Pseudorabies Virus Expressing Interleukin-18, Interferon-Gamma and PH20 Genes Promotes Systemic Antitumor Immunity
Pseudorabies virus (PRV) is considered to be a promising oncolytic virus that has potential as a cancer gene therapy drug. In this study, PRV-DCD-1-70 was used as a vector to carry exogenous genes IL-18, IFN-γ and PH20 to construct novel recombinant PRV, rPRV-PH20 and rPRV-IL-18-γ-PH20, and their tu...
Autores principales: | Han, Xiaohui, Sun, Jingshuai, Lv, Xiaocheng, Tang, Xiaoyu, Zheng, Yubin, Ma, Jinyun, Sun, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385555/ https://www.ncbi.nlm.nih.gov/pubmed/37513021 http://dx.doi.org/10.3390/microorganisms11071850 |
Ejemplares similares
-
Recombinant Porcine Interferon-α Decreases Pseudorabies Virus Infection
por: Song, Bowen, et al.
Publicado: (2023) -
Interferon-gamma response of PBMC indicates productive pseudorabies virus (PRV) infection in swine
por: Hoegen, Bärbel, et al.
Publicado: (2004) -
Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells
Publicado: (1989) -
Reporter Transgenes for Monitoring the Antitumor Efficacy of Recombinant Oncolytic Viruses
por: Semenova, A. V., et al.
Publicado: (2022) -
Updates to the antitumor mechanism of oncolytic virus
por: Bai, Yang, et al.
Publicado: (2019)